← Back to Search

Intervention (MBSR) for Randomized Controlled Trials

N/A
Waitlist Available
Research Sponsored by Women's College Hospital
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
age ≥ 60 years
English fluency
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 10-15 minutes
Awards & highlights

Study Summary

People living with subjective cognitive decline (SCD) or mild cognitive impairment (MCI) experience less efficiency in performing complex everyday tasks, which may result in a general sense of discontentment and decreased satisfaction with their overall functional performance. Additionally, SCD and MCI have been associated with concomitant anxiety, depressive mood, perceived stress, a decrease in emotional well-being and quality-of-life (QoL) among community-dwelling older adults. These concomitant psychosocial issues may result in emotional distress which further exacerbates cognitive decline. At the present time, there is a lack of evidence that supports pharmacologic interventions to ameliorate concomitant psychosocial issues with this particular population due to medication side-effects, drug-drug interaction and polypharmacy. Consequently, exploring alternative non-pharmacological interventions to assist in ameliorating psychosocial issues is an important consideration. Secondly, evaluating perceived satisfaction on functional performance with those living with SCD and MCI, and assessing interventions that may support this is also worthwhile to pursue. Primary care providers are often the first point of contact when older adults and their families become concerned about memory problems. Health care professionals, on an interdisciplinary Family Health Team (FHT), such as occupational therapists, are well-positioned to holistically address both the psychosocial and functional needs in a client/family centred way with this growing population in primary care. The study proposes to offer a Mindfulness-Based Stress Reduction (MBSR) program, which is an 8-week program that has been shown to be beneficial in alleviating emotional distress among adults living with physical and psychological issues in the general population.

Eligible Conditions
  • Randomized Controlled Trials

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~10-15 minutes
This trial's timeline: 3 weeks for screening, Varies for treatment, and 10-15 minutes for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Canadian Occupational Performance Measure (COPM)
Secondary outcome measures
Acceptance and Action Questionnaire (AAQ)
Cognitive and Affective Mindfulness Scale-Revised (CAMS-R)
Geriatric Anxiety Inventory (GAI)
+3 more
Other outcome measures
Geriatric Depression Scale (GDS)
Montreal Cognitive Assessment (MoCA)

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Intervention (MBSR)Experimental Treatment1 Intervention
Mindfulness-Based Stress Reduction (MBSR) - Intervention Arm
Group II: Control - Usual CareActive Control1 Intervention
Control
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Mindfulness-Based Stress Reduction (MBSR)
2018
Completed Phase 2
~1430

Find a Location

Who is running the clinical trial?

Queen's UniversityOTHER
362 Previous Clinical Trials
119,451 Total Patients Enrolled
Women's College HospitalLead Sponsor
99 Previous Clinical Trials
38,731 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
~7 spots leftby Mar 2025